Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A PCR-based assay for distinguishing between 293, 293T, and 293E cell lines.

Analytical biochemistry·2026
Same author

MSC-Derived Apoptotic Vesicles Restore Bone Marrow Niche Homeostasis in Postmenopausal Osteoporosis by miRNA-Mediated Suppression of MAPK and NF-κB Signaling Nodes.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Activating the vagus nerve-adrenal anti-inflammatory axis to delay aging: A randomized controlled trial protocol.

Contemporary clinical trials communications·2026
Same author

Intermittent hypobaric pressure induces selective senescent cell death and alleviates age-related osteoporosis.

Nature biomedical engineering·2026
Same author

David Baltimore (1938-2025): architect of the modern molecular approach to conquer leukemia.

Blood science (Baltimore, Md.)·2025
Same author

A phase 1/2 pilot study of acupuncture and moxibustion at Zusanli (ST36) as a prophylactic treatment in middle-aged and elderly individuals.

Frontiers of medicine·2025
Same journal

Clinical Europium fluorescent based lectin assays for mucin O-glycomics.

Methods in enzymology·2026
Same journal

A dual-color FRET assay for detection and quantitative analysis of O-glycopeptidases.

Methods in enzymology·2026
Same journal

Evolutionary genetic approaches to analyze mucins.

Methods in enzymology·2026
Same journal

Ex vivo imaging and enzymatic analysis of intestinal mucus.

Methods in enzymology·2026
Same journal

Glyco-TRAPP: A real-time glycocalyx permeability assay for assessing transmembrane mucin barrier function in live and fixed tissues.

Methods in enzymology·2026
Same journal

Quantitative imaging approaches to capture structural and functional dynamics of colonic mucus in health and disease in situ.

Methods in enzymology·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Mouse model for NRAS-induced leukemogenesis.

Chaitali Parikh1, Ruibao Ren

  • 1Rosenstiel Basic Medical Sciences Research Center, Department of Biology, Brandeis University, Waltham, Massachusetts, USA.

Methods in Enzymology
|April 1, 2008
PubMed
Summary
This summary is machine-generated.

Constitutive RAS pathway activation is common in human leukemias. This study presents a novel murine model for myeloid leukemias initiated by oncogenic NRAS, aiding research into leukemia pathogenesis and targeted therapies.

More Related Videos

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jul 6, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • RAS pathway activation is frequent in hematological malignancies, including leukemia.
  • The exact role of RAS activation in leukemogenesis remains unclear.
  • Previous animal models for NRAS-driven leukemogenesis have shown limited success.

Purpose of the Study:

  • To establish an efficient and relevant murine model for myeloid leukemias initiated by oncogenic NRAS.
  • To facilitate the study of molecular mechanisms in myeloid malignancy pathogenesis.
  • To provide a platform for testing targeted therapies against RAS-driven leukemias.

Main Methods:

  • Development of an improved bone marrow transduction/transplantation system in mice.
  • Introduction of oncogenic NRAS to initiate myeloid leukemias.
  • Utilizing the murine model for mechanistic and therapeutic studies.

Main Results:

  • An efficient and relevant murine model for NRAS-initiated myeloid leukemias was successfully established.
  • The model allows for in-depth investigation of leukemogenesis.
  • The model is suitable for preclinical testing of targeted therapies.

Conclusions:

  • Oncogenic NRAS can efficiently initiate myeloid leukemias in a relevant murine model.
  • This model is a valuable tool for understanding myeloid malignancy pathogenesis.
  • The model system supports the evaluation of novel therapeutic strategies for leukemia.